Group One Trading’s Bio-Techne TECH Stock Holding History

Group One Trading’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400	Closed	-$48K	–	8831
2021 Q3	$48K	Buy	+400	New	+$48.7K	﹤0.01%	6575

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Group One Trading's TECH Position: Q4 2021 in Review

Group One Trading sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 400 shares — an estimated $48K sold.

Group One Trading first reported a position in TECH in Q3 2021 and held it in 1 quarter. The position peaked at $48K in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

Group One Trading reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
Group One Trading sold 400 Bio-Techne shares in Q4 2021, an estimated $48K.
Group One Trading first reported a position in Bio-Techne in Q3 2021 and held it in 1 quarter.
Group One Trading's Bio-Techne position peaked at $48K in Q3 2021.
575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.